Associated Papers
SRSF2 mutations drive daunorubicin resistance in acute myeloid leukemia via THBS1 stabilization.
Ye W et al.
Journal of Experimental & Clinical Cancer Research : Cr, 2026
Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm.
Barosi G et al.
Haematologica, 2025
Extreme Gradient Boosting Tuned with Metaheuristic Algorithms for Predicting Myeloid NGS Onco-Somatic Variant Pathogenicity.
Pellegrino E et al.
Bioengineering (basel, Switzerland), 2023
37508780 (PubMed )
Supplement: bioengineering-10-00753-s001.zip › bioengineering-2428084-supplementary.xls › run24012023b_all
Mutational spectrum and prognosis in Chinese patients with prefibrotic primary myelofibrosis.
Cheng CK et al.
Ejhaem, 2022
35846205 (PubMed )
Supplement: JHA2-3-184-s002.xlsx › All_MPN_cases
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Sargas C et al.
Haematologica, 2021
33179471 (PubMed )
Supplement: 2020_263806_SARGAS_SUPPL.pdf
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.
Martin ES et al.
American Journal of Hematology, 2021
Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms.
Aguirre-Ruiz P et al.
Journal of Clinical Medicine, 2020
Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations.
Pangallo J et al.
Blood, 2020
Emerin binding to Btf, a death-promoting transcriptional repressor, is disrupted by a missense mutation that causes Emery-Dreifuss muscular dystrophy.
Haraguchi T et al.
European Journal of Biochemistry, 2004
Select a paper to view details